Endo Tax Edge for Deals Mimics Valeant Playbook: Real M&A

Endo Health Solutions Inc.’s recent acquisition designed to lower its tax rate may be following Valeant Pharmaceuticals International Inc.’s blueprint for a lucrative takeover spree.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.